STOCK TITAN

Veeva Systems Inc - VEEV STOCK NEWS

Welcome to our dedicated news page for Veeva Systems (Ticker: VEEV), a resource for investors and traders seeking the latest updates and insights on Veeva Systems.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Veeva Systems's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Veeva Systems's position in the market.

Rhea-AI Summary
Veeva Systems announced that 16 of the top 20 biopharmas are using Veeva Crossix Prime Segments to increase media efficiency, helping them reach highly-qualified health audiences. Since its launch in April 2023, these segments have enabled biopharmas to target consumers 10 times more effectively than standard health audience segments. Veeva Crossix's privacy-safe data allows marketers to achieve various campaign goals, with Prime Segments targeting specific patient populations and Reach Segments focusing on broad awareness and ROI at scale. The company's commitment to data privacy and compliance is evident through their patented SafeMine technology.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
News
Rhea-AI Summary
Veeva Systems launches the Veeva AI Partner Program to provide advanced technology and support for integrating GenAI solutions with Veeva Vault applications. The program includes Vault Direct Data API training, support, and a Sandbox for developing partner applications. Veeva aims to enable AI for the life sciences industry.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
AI
-
Rhea-AI Summary
Veeva Systems announces leaders from Bayer, Genentech, Novo Nordisk, and Takeda as keynote speakers at the 2024 Veeva Commercial Summit in Boston. The summit will focus on customer-centric engagement strategies, with Veeva CEO Peter Gassner discussing the recent delivery of Veeva Vault CRM. Leading biopharmas will share insights on modern commercial data approaches, marketing analytics, operational foundations, and global content strategies.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary
Veeva Systems (NYSE: VEEV) announced the launch of Veeva Vault CRM Campaign Manager, a new marketing application designed for healthcare professionals. The application aims to streamline non-personal promotion through seamless integration with sales, promoting customer centricity. Features include campaign management, segment creation, mass email capabilities, field suggestions, landing pages, and content builder. The product is set to be available in late 2024, catering to life sciences companies of all sizes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
Veeva Systems announces successful adoption of Vault CRM by early customers in the U.S. and Europe, with plans for migration of existing Veeva CRM customers. The company expresses gratitude to customers and product team for the achievement.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.56%
Tags
none
-
Rhea-AI Summary
Veeva Systems announces increased adoption of Vault EDC with eight of the top 20 biopharmas standardizing on it, enabling faster study builds and streamlined processes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.1%
Tags
none
Rhea-AI Summary
Veeva Systems (VEEV) to present at Morgan Stanley Technology, Media & Telecom Conference on March 6, 2024. CFO Brent Bowman to speak at 9:30 a.m. Pacific Time. Webcast available on Veeva's investor relations website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.93%
Tags
conferences
-
Rhea-AI Summary
Veeva Systems Inc. reports Fiscal Year 2024 Total Revenues of $2,363.7M, up 10% Year Over Year, with Q4 Total Revenues of $630.6M, up 12% Year Over Year. The company achieved growth in Subscription Services Revenues and introduced new products like the Veeva Compass Suite and Clinical Platform. Despite a decrease in net income for Q4, Veeva remains optimistic about its future growth and impact on the life sciences industry.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.55%
Tags
-
Rhea-AI Summary
Boehringer Ingelheim adopts Veeva Vault Clinical and Veeva Vault RIM for streamlined clinical and regulatory management in its animal health business unit, aiming to accelerate the development of new medicines for animals and improve operational efficiency.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.15%
Tags
partnership
Rhea-AI Summary
Veeva Systems introduces Veeva Vault Submissions Publishing eLearning, a new regulatory information management application to educate users on key publishing processes. The on-demand training program aims to streamline development of compliant content, increase efficiency, and enhance employee qualification.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.78%
Tags
none
Veeva Systems Inc

NYSE:VEEV

VEEV Rankings

VEEV Stock Data

33.35B
147.86M
8.2%
84.17%
1.48%
Software Publishers
Information
Link
United States
Pleasanton

About VEEV

veeva systems inc. is a leader in cloud-based software for the global life sciences industry. committed to innovation, product excellence, and customer success, veeva has more than 300 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. veeva is headquartered in the san francisco bay area, with offices in europe, asia, and latin america. for more information, visit www.veeva.com.